Sagimakgol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sagimakgol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sagimakgol Today - Breaking & Trending Today

iNtRON is finalizing the SAL200 Tech Transfer

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Tech Transfer process of SAL200, endolysin-based new. ....

United States , Soult Ukpyolsi , South Korea , Kyonggi Do , Sang Hyeon , Gyeonggi Do , Republic Of Korea , Ntron Biotechnology Inc , Intodeworld Inc , Bd Team , Tae Kyu Tk Bd Team Leader , Tech Transfer , Kyung Won , Vice President , Tae Kyu , Intron Biotechnology ,

iNtRON developed advanced bacteriophage engineering platform technology based on modified random mutagenesis

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) has announced today that the Company has established the 2nd generation technology of. ....

United States , Soult Ukpyolsi , South Korea , Kyonggi Do , Gyeonggi Do , Republic Of Korea , Jee Soo , Ntron Biotechnology Inc , Intodeworld Inc , Bd Team , Tae Kyu Tk Bd Team Leader , Robot Bacteriophage , Mcas System , High Throughput Screening , Kyung Won , Vice President , Tae Kyu , Intron Biotechnology ,

iNtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200

INtRON completes the sponsorship transfer process for the US Phase 2 study of SAL200 ....

United States , Soult Ukpyolsi , South Korea , Kyonggi Do , Gyeonggi Do , Republic Of Korea , Ntron Biotechnology Inc , Intodeworld Inc , Bd Team , Tae Kyu Tk Bd Team Leader , Us Center , Kyung Won , Antimicrobial Resistance , Disease Control , Big Pharma , Vice President , Tae Kyu , Icrowd News Wire , Ponsorship Transfer , The Sponsorship , Ntron Completes ,

iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that iNtRON has developed its unique CRISPR/Cas system customized for the. ....

United States , Soult Ukpyolsi , South Korea , Kyonggi Do , Gyeonggi Do , Republic Of Korea , Jee Soo , Ntron Biotechnology Inc , Intodeworld Inc , Bd Team , Tae Kyu Tk Bd Team Leader , Bio Drug Business , Kyung Won , Vice President , Tae Kyu , Intron Biotechnology ,

iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

/PRNewswire/ iNtRON Biotechnology ("iNtRON", www.intodeworld.com) announced today that CDL200, a novel biological drug candidate under the development of. ....

United States , Soult Ukpyolsi , South Korea , Kyonggi Do , Sang Hyeon , Gyeonggi Do , Republic Of Korea , Ntron Biotechnology Inc , Intodeworld Inc , Bd Team , Tae Kyu Tk Bd Team Leader , Kyung Won , Inflammatory Bowel Disease , Vice President , Tae Kyu , Intron Biotechnology ,